Revisiting early hypothyroidism screening in infants with Down syndrome

I B Purdy1, N Singh1, W L Brown1

  • 1Division of Neonatology, Department of Pediatrics, David Geffen School of Medicine at UCLA, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, USA.

Insights

Infants with Down syndrome have a higher incidence of hypothyroidism than previously thought, with over 32% identified before 4 months of age. Early detection of thyroid dysfunction is crucial for this population.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Down syndrome is associated with an increased risk of hypothyroidism.
  • Standard screening for hypothyroidism in infants with Down syndrome occurs at 6 months.
  • Early identification of thyroid dysfunction is critical for infant development.

Purpose of the Study:

  • To determine the incidence of hypothyroidism in infants with Down syndrome before the standard 6-month retesting.
  • To compare early hypothyroidism rates with established childhood estimates.

Main Methods:

  • Retrospective observational cohort study of 122 infants with Down syndrome.
  • Analysis of thyroid hormone laboratory tests (thyroxine, thyroid-stimulating hormone) prior to 4 months of age.
  • Cross-linking demographic and diagnostic data with thyroid function tests.

Main Results:

  • Any hypothyroidism was identified in 32.5% of infants.
  • 17.5% had primary hypothyroidism requiring T4 therapy.
  • 15% had compensated hypothyroidism, and 67.5% were euthyroid.

Conclusions:

  • The incidence of any hypothyroidism in infants with Down syndrome is higher than previously reported.
  • Early screening for hypothyroidism is warranted in infants with Down syndrome, even with normal newborn screens.
  • Findings highlight the need for earlier thyroid function monitoring in this population.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
20
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
28
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
20
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
19
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K